机译:Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA;
Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA;
Genentech Inc, Translat Oncol, San Francisco, CA 94080 USAGenentech Inc, Biochem Pharmacol, San Francisco, CA 94080 USA;
metabolite profiling; metabolic subtypes in PDAC; glycolysis; lipid synthesis; biomarkers for metabolic inhibitors;